Abstract
Background
Cervical cancer is a widespread cancer among women worldwide. In this study, we evaluated the role of diffusion weighted magnetic resonance imaging (DWI-MRI) in diagnosis of cervical carcinoma with pathological diagnosis taken as the reference. The study included 70 patients in whom cancer cervix had been suspected clinically or by transvaginal U/S and confirmed by biopsy. The control group consisted of 40 patients with a normal cervix who performed MRI for other pelvic disorders. Pelvic MR with DWI and dynamic contrast enhanced MRI (DCE-MR) were done for all patients.
Results
Both DW-MRI and DCE-MRI revealed the same sensitivity, specificity, PPV, and accuracy; 100%, 50%, 97%, and 97%, respectively. The mean ADC value for malignant lesions was (0.82 × 10−3 ± 0.1 SD mm2/s). While the mean ADC value in the control group is (1.56 × 10–3 mm2/s). ADC value of (1.07 × 10−3 mm2/s) is a cut-off between normal cervical tissue& malignant cervical lesion with a sensitivity 97% and specificity 95.5%
Conclusion
Each of the (DW-MRI) and (DCE-MRI) sequences when added to the non-contrast MRI sequences in the estimation of cancer cervix had elicited the same sensitivity, specificity, and accuracy. DW–MRI was significantly beneficial in terms of diagnostic performance. For patients who cannot receive contrast medium, dynamic contrast-enhanced imaging can be replaced by DWI. The ADC value in case of cervical cancer was significantly lower than in the non-affected cervical tissue.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
 ; Mokhtar, Omnia 2 ; Adel, Lamia 3 ; Hassan, Reda 2 ; Ibraheim, Manal 4 ; Kamal, Amro 5
 
; Mokhtar, Omnia 2 ; Adel, Lamia 3 ; Hassan, Reda 2 ; Ibraheim, Manal 4 ; Kamal, Amro 5 1 Beni-suef University, Radiology Department, Faculty of Medicine, Beni Suef, Egypt (GRID:grid.411662.6) (ISNI:0000 0004 0412 4932)
2 National Cancer Institute of Cairo, Radiology Department, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
3 Cairo University, Radiology Department, Faculty of Medicine, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
4 Menofia University, National Liver Institute, Shebeen El-Kom, Egypt (GRID:grid.411775.1) (ISNI:0000 0004 0621 4712)
5 National Cancer Institute of Cairo, Surgery Department, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)





